Sponsor content
320 result(s) found, displaying 41 to 50
-
Australian public assessment report (AusPar)Radicava (edaravone) was approved to treat adults with a diagnosis of amyotrophic lateral sclerosis who are independent in activities of daily living with normal respiratory function and where treatment is initiated within two years of disease onset.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABIRATERONE-TEVA abiraterone acetate 500 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABIRATERONE-TEVA abiraterone acetate 250 mg film-coated tablet bottle pack.
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd